Provided by Tiger Trade Technology Pte. Ltd.

Axis Capital

101.28
+0.24000.24%
Pre-market: 100.50-0.7800-0.77%06:01 EDT
Volume:466.73K
Turnover:47.06M
Market Cap:7.49B
PE:8.20
High:102.28
Open:102.28
Low:99.40
Close:101.04
52wk High:110.34
52wk Low:84.81
Shares:73.97M
Float Shares:68.59M
Volume Ratio:0.78
T/O Rate:0.68%
Dividend:1.76
Dividend Rate:1.74%
EPS(TTM):12.35
EPS(LYR):12.35
ROE:16.21%
ROA:2.65%
PB:1.29
PE(LYR):8.20

Loading ...

Axis Capital Downgrades Coal India to Reduce from Add, Price Target is INR435

MT Newswires Live
·
Jan 30

Axis Capital price target raised to $120 from $110 at Roth Capital

TIPRANKS
·
Jan 29

AXIS Capital Is Maintained at Neutral by B of A Securities

Dow Jones
·
Jan 29

AXIS Capital Holdings Ltd : Bofa Global Research Cuts Price Objective to $115 From $119

THOMSON REUTERS
·
Jan 29

Analysts Offer Insights on Financial Companies: Deutsche Bank AG (DB), Navient (NAVI) and Axis Capital (AXS)

TIPRANKS
·
Jan 29

Analysts’ Top Financial Picks: Banca Mediolanum SpA (BNMDF), Axis Capital (AXS)

TIPRANKS
·
Jan 29

AXIS Capital Q4 Net Income USD 282 Million

Reuters
·
Jan 29

Bermuda's AXIS Capital Q4 underwriting income up 42%

Reuters
·
Jan 29

Axis Capital Holdings Q4 Adj. EPS $3.25 Beats $3.11 Estimate, Sales $1.734B Beat $1.516B Estimate

Benzinga
·
Jan 29

AXIS Capital Reports Fourth Quarter Net Income Available to Common Shareholders of $282 Million, or $3.67 per Diluted Common Share and Operating Income of $250 Million, or $3.25 per Diluted Common Share

THOMSON REUTERS
·
Jan 29

AXIS Capital Q4 Combined Ratio 90.4%

THOMSON REUTERS
·
Jan 29

AXIS Capital Q4 EPS USD 3.67

THOMSON REUTERS
·
Jan 29

Axsome Therapeutics (AXSM) Valuation Check As Phase 3 AXS 14 Fibromyalgia Trial Gets Underway

Simply Wall St.
·
Jan 28

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jan 26

Axsome Therapeutics (AXSM) Is Up 7.4% After Advancing AXS-14 Into Phase 3 FORWARD Fibromyalgia Trial

Simply Wall St.
·
Jan 23

Earning Preview: Axis Capital revenue is expected to increase by 11.73%, and institutional views are leaning positive

Earnings Agent
·
Jan 21

Arch Capital Group Ltd. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 21

Axis Capital Survey Finds AI Drives Cyber Threat Surge and Budget Increases

Reuters
·
Jan 20

RBC Capital Reaffirms Their Buy Rating on Axis Capital (AXS)

TIPRANKS
·
Jan 17

BofA Securities Adjusts Axis Capital Price Target to $109 From $115, Maintains Neutral Rating

MT Newswires Live
·
Jan 17